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Nitric oxide (NO) is a highly reactive free radical gas that is colorless and odorless at 
room temperature. It is known to be a toxic atmospheric pollutant that also causes ozone 
layer depletion [Coolman and Robarge, 1995]. NO was identified as a biological molecule 
upon demonstration, in 1987, of its generation by an enzyme [Moncada et .al., 1989]. This 
has lead to an increase in research activity investigating n~tric oxide's physiological 
functions and pathological effects. 
NO is synthesized endogenously by many mammalian cells including macrophages, 
neutrophds, endothelial cells, and hepatocytes [Conner and Grisham, 1993]. Endogenous 
NO is also present in the exhaled air from animals and humans in concentrations on the 
order of 1 0 ppb [Gustafsson et al., ] 991] . NO has several important physiological roles 
such as blood pressure regulation, neurotransmission, andimmunoregulation. However, 
the underproduction or overproduction of NO is at least partly responsible for the 
pathogenesis of several conditions such as hypertension, septic shock, and perhaps 
cirrhosis and diabetes [Moncada and Higgs, 1993 ; Corbett et aI., 1993]. 
1.1 Biosynthesis of nitric oxide. 
NO is produced in vertebrate cells by the enzyme catalyzed oxidation of L-arginine to 
citrulline. This enzyme, called nitric oxide synthase (NOS), may be present in cells as a 
constitutive and/or inducible enzyme. The constitutive isoform of NOS (cNOS) is Ca2+ I 
calmodulin dependent and is activCl!ted by stimuli such as pulsatile blood flow or shear 
stress due to increased blood flow. Activation of this enzyme causes a short-lasting 
release of NO on the order ofa few pica moles mg-1 min-I [Conner and Grisham, 1993]. 
This release is inhibited by L-arginine analogs but not glucocorticoids. The inducible 
isoform of NOS (iNOS), on the other hand, is controlled at the transcriptional level and is 
activated by cytokines and bacterial endotoxins. It is Ca2 i I calmodulin independent and 
causes a long-lasting release of NO on the order ofnanomoles mg-) min-! [Conner and 
Grisham, 1993]. The induction of iNOS is inhibited by glucocorticoids and its function is 
inhibited by L-arginine analogs. The inducible form of NOS is mainly found in 
macrophages and, in some cases, other cells such as endothelial cells and pancreatic ~-
cells [Kroncke et aL, 1995]. 
1.2 NO in tbe cardiovascular and pulmonary system. 
In the cardiovascular system, NO is essential for regulating blood flow and blood 
pressure [Moncada, 1992]. NO in synergy with prostacyclin inhibits platelet aggregation 
which prevents clots from forming in the blood vessels. NO acting alone inhibits platelet 
adhesion [Radomski and Moncada, ] 991] as well as adhesion of leucocytes to the 
microvascular endothelium [Kubes et al., 1991 ] and the resultant endothelial injury. In the 
pulmonary system, inhaled NO has been found to reverse pulmonary hypertension [Pepko-
Zaba et aL, ] 991] and protect against respiratory distress syndrome [Rossaint et aL, 
1993]. The calcium independent isoform of NOS can be induced in smooth muscle cells 
as weU as in endothelial ceJls. The generated NO leads to vascular relaxation that cannot 
be reversed by vasoconstrictors This vasodilation and resistance to vasoconstrictors is 
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characteristic of septic shock as wen as hypotension induced by cytokine therapy in 
patients with cancer [Moncada, 1992]' Generation oflarge quantities of NO by iNOS 
may lead to tissue damage, cirrhosis [Vallance and Moncada, 1991] and cardiac 
dysfunction associated with dilated cardiomyopathy (primary myocardial disease) [de 
Belder et al., 1993]. The underproduction of NO lead!s to hypertension. 
1.3 NO in the gastrointestinal system. 
In addition to maintaining vasodilator tone in the gastrointestinal system, NO in 
synergy with prostacyclin apparently maintains the integrity of the mucosal layer. NO also 
appears to mediate some forms of muscular relaxation including the dilation of the 
stomach to adapt to incf,eases in intragastric pressure [Rand, 1992], the relaxation of the 
circular sigmoid muscle of the colon [Tam and Hiner, ] 992], and the anal spincter muscle 
[Burleigh, 1992]. NO may be the key to finding a cure for impotence as it is responsible 
for effecting penile erection [Ignarro et aI., 1990]. 
As in the cardiovascular system, NO-dependent dilator tone is essential for proper 
functioning of the organs. ]nadequat,e production of NO in the corpus cavemosum 
(spongy body of the penis) may be the cause for male impotence while deficiency of NOS 
in the pyloric tissue is the cause ofhypertropic pyloric stenosis (blockage of the passage 
connecting the stomach to the duodenum) in infants [Vanderwinden et ai., 1992]. A 
deficiency of NOS in adult gastrophageal tissue seems to be the cause of achalasia (failure 
of smooth muscle in the gastrointestinal tract to relax.) [Mearin et ai., 1993]. 
3 
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1.4 NO in the central nen'ODS system. 
In the brain, NO is responsmble for a phenomenon known as long-tenn potentiation that 
is thought to be linked to memory formation [CollEngridge et at, 1983]. NO may also 
have a physiological role in vision, feeding behavior, and olfaction [Moncada and Higgs, 
]993]. 
NO cytotoxicity resulting from its overproduction may be partially responsible for 
stroke, Huntingdon's chorea, cerebral ischemia (deficiency of blood in the brain), epilepsy 
[Moncada et aI., 1989], multiple sderosis, Alzheimer' s disease, Parkinson's disease, and 
dementia of acquired immune deficiency syndrome [Moncada and Higgs, 1993], 
1.5 NO as ,a cytotoxic and cyto,static agent. 
Macrophages and neutrophils synthesize NO as a defense against microorganisms such 
as bacteria [Hibbs et aI., ] 990]. The biochemical basis for this cytotoxicity of NO is the 
r,eaction of NO with iron containing moieties in key enzymes of the respiratory cycle 
andlor DNA damage in the target cells [Moncada and l-Iiggs, 1993], NO is thus involved 
in non-specific immunity and the seemingly non-specific nature of its cytotoxicity may 
prove to be deleterious not only for tumor cells and invading microorganisms but also for 
NO generating cells and their immediate neighbors . The NO generated by iNOS could 
thus be responsible for the damage of healthy and normal tissue leading to the 
pathogenesis of rheumatoid arthritis, ulcerative colitis [Moncada and Higgs, ] 993], insulin 
dependent diabetes mellitus (100M) [Bendtzen, 1989] and asthma [Moncada, 1994]. 
Inhibition of NO generation by introducing L-arginine analogs i.s shown to alleviate 
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1.6 Biological reactions €If nitric oxide. 
The biological actions of NO differ from other major mediators in that (a) its functions 
are governed by its chemical properties as opposed to its shape, (b) it can diffuse freely 
from the site of synthesis to the adjacent tissues, and (c) no enzymatic mechanism is 
requir,ed for its removal [Conner and Grisham, 1995]. As a very reactive molecule, NO 
reacts with severa] species in aqueous media. The byproducts of some of these reactions 
may also be of physiological and pathological significance. 
1. 6.1 Reaction with oxygen. 
NO reacts with the dissolved oxygen in the following manner. 
(1.1 ) 
(1.2) 
Nitrous anhydride (N20 3) then decomposes in aqueous media to form nitrite (N02") 
[Lewis and Deen, 1994] according to 
(1.3) 
Nitrous anhydride is a nitrosating agent and thus a cytotoxin that denatures DNA by 
nitrosati.on of the primary amines on DNA bases. It also may ni trosate secondary amines 
to yield carcinogenic and mutagenic products [Tannenbaum et aI., 1991] 
} _ 6. 2 Reaction with sliperoxide. 
Superoxide (02) is an oxygen free radical that is co-synthesized with NO by 
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macrophages and neutrophils during immunological reactions. It reacts with NO to form 
the peroxinitrite (ONOO-) radical [Huie and Padmaja, 1993]. 
(1.4) 
Peroxinitrite is a strong oxidant that reacts in aqueous medium to form a very highly 
reactive "hydroxyl-like" radical [Beckman et at. ) 199Gb]. Peroxinitrite and the hydroxyl 
ion can cause lipid membrane peroxidation [Hogg et aI. , 1992] and the denaturing of DNA 
[Delaney and Eizirik, 1996]. 
I. 6.3 Reaction with the sulphydryl groups. 
NO reacts with the sulphydryl groups on proteins to form S-nitrosothiols which are 
more stable than NO, Therefore, the sulphydryl groups on proteins are potential NO 
earners . S-nitrosothiols are potent vasodilators and platelet inhibitors [Stamler et al., 
1992], 
1.6.-1 Reaction 'with metalloproteins. 
The interactions of NO with metall.oproteins constitute rel.evant molecular mechanisms 
accounting for its signal transduction and cytotoxicity. NO readily reacts with the metal 
cent,ers of proteins including iron, iron-sulfur and zinc-sulfur clusters [Radi, 1996], These 
interactions with NO lead to the formation of a metal nitrosyl complex resulting in a 
modification of the structure and/or function of these proteins. 
In blood, excess NO is scavenged by oxyhemoglobin to form met-hemoglobin and 
nitrate, or deoxyhemoglobin to form a stable iron nitrosyl complex with its iron core. This 













molecule [Radi, 1996]. NO also reacts with the iron core in cytochrome c oxidase and 
cytochrome P450 which leads to inhibition of mitochondrial electron transport [Cleeter et 
all., 1994]. 
The interaction of NO with the iron-sulfur cluster of mitochondrial aconitase results in 
the inhibition of Krebs cycle resulting from enzyme inactivation [Radi, 1996]. The 
interaction of NO with zinc present lin the zinc-sulfur cluster of enzyme alcohol 
dehydrogenase leads to inhibition of the DNA binding ability of the enzyme [Radii, 1996). 
1. 7 NO and Diabetes Mellitus. 
Clinical diabetes mellitus is a syndrome of inadequate glucose metabolism causing 
inappropriately high levels of glucose in the blood. This may occur due to a total absence 
of the hormone insulin or a reduction in the biological effectiveness of insulin. Diabetes is 
classified as insulin dependent (type]) or non-insulin dependent (type 2). Type 1 is a 
severe ailment characterized by an almost total absence of insulin due to death or severe 
dysfunction of the p cells in pancreatic islets. It is an autoimmune disease in which NO is 
believed to be one of the mediators of cell death [McDaniel ef ai, 1996]. This thesis 
develops and models the system in which p cells could be exposed to controlled 




NITRIC OXIDE: A MEDIATOR OF PANCREATIC I3-CELL DYSFUNCTION? 
Insulin-dependent diabetes mellitus is an autoimmune disease which appears to develop 
over a long period of time before becoming clinically manifest [Eisenbarth, 1986]. This 
prediabetic period is characterized by inflammatory reaction in the vicinity of the 
pancreatic islets and infiltration of the islets by macro phages and lymphocytes resulting 
specifically in the death of the insulin producing ~-cells [Mandrup-Poulson et al., 1990; 
Castano and Eisenbarth, 1990]. Inflammatory products of these macrophages such as 
cytokines and free radicals have been implicated in the destruction of pancreatic J3-ceUs 
[Corbett and McDaniel, 1992]. Cytokines are glycoproteins synthesized in a variety of 
different cells, in response to numerous stimuli, that act in picomolar to nanomoJar 
quantities to regulate target cell function [Nathan and Sporn, 1.991]. 
Two models have been proposed in which NO appears to be responsible for ~-cell 
death. The first is that the release ofcytokines by activated macrophages in the vicinity of 
the ~-cens induces endogenous NO production in 1he (3-cells, resulting in self destruction 
[Corbett and McDaniel, ] 992]. The second modd is a scenario in which cytokine 
activated macrophages and pancreatic endothelial cells produce large amounts of NO 
which, acting alone or in cooperation with oxygen free radicals, lead to ~-cell destruction 
[Kolb and Kolb-Bachofen, 1992]. Much of the research investigating NO cytotoxicity has 
focused on determining the effects of cytokines [Dunger et aI., 1996; Rabinovitch et aL, 
1990], cytokine induced NO [Corbett et aI., 1993; Dunger et aI., 1996], and intracellularly 
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and extraceHularly generated NO, using NO-donor compounds [Eizirik et al., 1996], on 
the functron and viability of pancreatic ~-cells , 
2.1 Effects of intracellular NO generation. 
Macrophage generated cytokines, primarily interlukin-l ~ (IL-I ~), tumor necrosis 
factor a (TNF-a), and imerferon y (fNF-y) induce NO formation in ~-cells [Corbett and 
McDaniel, 1992]. The endogenously generated NO can inhibit the normal endocrine 
function ofthe ~-cens by obstructing their mitochondrial function [Drapier et aI., 1986] or 
by causing cell death by initiating DNA strand breaks [Fehsel et aL, 1993; Delaney and 
Eizirik, 1996], Similar effects have been observed when using compounds that generate 
NO intraceUuiarly [Green et al., 1993]. 
2.1.1 Effects of cytokine inducetlNO. 
The r,esults of the experiments aimed at determining the effect of cytokines and 
cytokine induced NO on j3-cells have been varied and often contradictory [Corbett et aL, 
1993; Eizirik et al., 1994, Suarez-Pinzon et al. , 1994; Corbett.and McDaniel, 1995]. This 
is likely due to 1) use of ceLIs extracted from different mammalian species such as rats, 
mice and humans [Kawahara and Kenney, 199]]; 2) different methods of cell preparation 
(islet culture vs culture of purified j3-cells as a monolayer) since the matrix can control 
how cells respond to cytokines [Nathan and Sporn, ]991]; 3) the species the cytokines 








2.1.1.1 Effect oj NO on rat pancreatic islets. 
Rat pancreatic islets are by far the most susceptible to the effects of cytokines and 
cytokine induced NO [Welsh et al., 1994] when compared with islets from mice and 
humans. Several researchers [Corbett et ai , 1992; Corbett and McDaniel, 1995; Dunger 
et a1, 1996] have observed IL-l ~ induced NO generation in rat ~-cells paralleled by 
significant inhibition of glucose oxidation, inhibition of glucose stimulated insulin 
secretion, and DNA da:mag1e. However, other researchers have been able to dissociate the 
inhibitive actions of IL-I ~ from those of IL- ] ~ induced NO and claim that IL- 1 f) induced 
inhibition of j3-ceH function and the subsequent cell death follow NO-dependent as weB as 
NO-independent pathways [Anderson et aI., 1994; Suarez-Pinzon et aL, 1994]. In at 
monolayer culture of rat f)-cells, lysis was observed only when the cells were exposed to 
combinations oflL-I, TNF-a and INF-y obtained from rodents. Individually, these 
cytokines, as well as human cytokines, did not exhibit any cytotoxicity towards rat f)-cells 
[Pukel et a1., 1988]. 
2.1. 1. 2 £;!fect qf NO on murine pancreatic islets. 
In murine islets, the presence ofTNF-a or INF-y in addition to IL-J was necessary to 
induce NO production [Rabinovitch et aI., 1996]. Cytokine induced NO was at least 
partially responsible for inhibition of insulin secretion [We1sh and Sandler, 1992] by 
murine islets. However, the inhibition of insulin secretion was achieved without impairing 
~-cell mitochondrial function. 
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2.1.1. 3 Effect of NO on human pancreatic islets. 
Human pancreatic islets seem to be the least susceptible to the cytotoxic effects of 
cytokines [Eizirik et al., 1993]. Cytokines IL-l~, TNF-a:, and INF-y, were found to cause 
human .~-celllysis when a monolayer of ~-cells was exposed to the individual cytokines. 
The ~-cens were more potently lysed when exposed to a combination of all three 
cytokines [Rabinovitch et aI., 1990]. However, insulin secretion was slightly stimulated by 
exposure to a combination ofIL-l~, TNF-a:, and INF-y [Corbett et aI., 1993]. NO 
generation in human islets was found to take place only in the presence of more than one 
cytokine, as in murine islets [Rabinovitch et aI., 1994]. In some cases, [Corbett et aI., 
1993] cytokine induced NO was partially responsible a for decrease in islet function, while 
in other cases i[Rabinovitch et a1., 1994; Eizirik et aI., 1994] islet function was totally 
unimpaired by cytokine induced NO. 
2~1.2 Effects ofintracellularly generated NO. 
Chemicals such as hydroxylamine and Roussin's black salt (RBS) cause intracellular 
NO release .. Hydroxylamine has been proposed to be an intennediate in the arginine-NO 
pathway [DeMaster et aI., 1989]. The oxidation of hydroxylamine to NO is catalyzed by 
oxidative enzymes such as catalase that are present in all cells. RES, on the other hand, 
contains iron-sulfur cluster mtrosyls containing 7.0 moles ofligated NO per mole of RES. 
RES is lipid soluble and accumulates in cell membranes acting as a protracted source of 
NO [Eizi1rik et al., 1996]. However, RBS also decomposes in solution releasing NO, iron, 
and sulfur. 
Hydroxylamine has been used with rat [Green et al., 1993] and mouse [Panagiotidis et 
aI., 1995] islets. In these rodent islets, hydroxylamine greatly inhibited islet insulin 
secretion. RBS also causes inhibition of insulin release in human and rat pancreatic islets. 
However, the effect is more potent in rat islets [Eizirik et a1. , 1996]. 
,- . 
2.2 Effect of extracellularly generated NO. 
NO-donor compounds such as sodium nitroprusside (NP) [Kroncke et ai. , 1993 ; 
Eizirik et al. , 1994], 3-morphohnosydnonimine (SIN-I) [Green et aI., 1993; Eizirik ,et aI. , 
1996; Panagiotidis et aL, ]995; Delaney et aL, 1993; Kroncke et aI., 1993], S-nitroso-N-
acetyl-penicillamine (SNAP) [Kroncke et aL, 1993; Green et a1., 1993], S-
nitrosoglutathione (GSNO) [Green et aI. , 1993; Eizirik et aI. , ]996], and streptozotocin 
(STZ) [Eizirik et aI. , ] 994; Kaneto et a1., ] 995; ZuccoHo et aL, ] 995] have been used to 
study the effects of NO on ~-cel1s. AU of these compounds release NO spontaneously in 
solution, except SNAP and GSNO whose decomposition is catalyzed by external vascular 
membranes [Kowaluk and Fling, ] 990]. 
Researchers using NO-donor compounds have reported NO-dependent inhibition of 
insulin secretion accompanied by cell lysis in ~-cells obtained from rats [Green et aI. , 
1993; Eizirik et aI., 1994; Delaney et ai., 1993 ; Kroncke et aI., 1993], mice [Eizirik et aL, 
1994; Zuccollo et aI. , 1995; Panagiotidis et ai., 1995] and humans [Eizirik et ai., ] 994; 
Eizirik et aI. , J 996]. The experiments, however, seem to be plagued with several 
problems that introduce uncertainty in the interpretation of the results . 
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2.2.1 Shortcomings in experiments with NO-t[onor compou.nds. 
The experiments using NO-donor compounds to evaluate the effect of NO on 
pancreatic ~-cens have the following drawbacks: 
1) Several of the compounds release additional species such as superoxide, as in 
the case ofSrN-l [Green et a1., 1993]. Superoxide reacts with NO to form peroxinitrite, a 
species more damaging than NO [Huie and Padmaja, 1993]. Another compound, STZ, is 
an alkylating agent in addition to releasing NO [Kanetoet aI., 1995] and may cause 
damage through NO independent-pathways. A study using STZ as a NO-donor 
compound showed that NO cone-entrations relatively lower than those produced by IL-J ~ 
in rat islets led to cell lysis [Kaneto et aI., 1995]. This may indicate the existence of NO-
independent cytotoxic mechanisms. 
2) NO-donor compounds do not release NO at a steady rate . Thus, the NO 
concentration vs time profile is not necessarily constant [Ramamurthi, 19961 This implies 
that NO concentrations may reach very high and physiologically unrealistic values. In 
addition, the cells are exposed to an unsteady-state NO concentration profile. In most 
experiments, a known amount of NO-donor compound is used without any reference to 
I . , 
the kinetics of NO release by that compound. 
3) The experiments are conducted in unstirred containers having a small volume 
of stagnant culture medium. There is no assurance that all the cells see the same 
concentrations of NO. There is also an accumulation of NO and its reaction products with 
other species in the aqueous medium that may prove to be detrimental to the function of 
the cens. 
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4) Chemical donor-generated NO is ~-cell non-specific [Kroncke et ai., 1993], 
causing damage to aU the islet cells. However, pancreases from animals and humans with 
IDDM are deficient in f3-cells alone [Foulis, 1987]. This may be the result of the above 
mentioned defects in the experiments using chemical NO donors. 
2.3 Thesis Objectives. 
The thesis objective is to design a system to achieve controlled and steady-state NO 
concentrations in the aqueous phase to which the cells are exposed (explained in Chapter 
3). This would eliminate the use of NO-donor compounds and the accompanying 
experimental uncertainties. The specific aims of the thesis are defined below. 
2.3.1 Specific Aim #1. 
The first aim is to design and build an apparatus capable of delivering NO in the 
aqueous phase to pancreatic fj-cells. The delivery should be designed for a wide range of 
steady-state NO concentrations in an environment that provides no other species for NO 
to react with, except the dissolved oxygen, while ensuring that all the ceUs present in the 
apparatus are exposed to the same NO concentration. The system should also be designed 
so that there is no accumulation of NO or its reaction products in the vicinity of the cells. 
2.3.2 Specific Aim #2. 
The second aim is to model the NO delivery device and the subsequent reaction with 
the dissolved oxygen to predict the NO concentration to which the cells will be exposed. 
This will be achieved by adapting an existing model (explained in Chapter 4) tc predict the 
aqueous NO concentration at the delivery device cutlet. Equations that describe the 
14 
downstream liquid mixing behavior and those that quantify the reaction of NO with 
dissolved oxygen will be used to predict the NO concentration in the vicinity of the cells, 
The model will be validated at room temperature and physiological temperature (3TC) by 
measuring the NO concentration with a NO probe, 
2 .. i.3 Specific Aim #3. 
The final aim of this thesis is to perform experiments involving the exposure of ~-ceHs 
to controlled NO concentrations and establish the procedure for performing the 
experiments and the subsequent samp[e assays. A few experiments will be performed to 
ascertain whether the system can be used to study the effects of NO on p-cells, Samples 
will be collected and assayed to determine insulin content and to ascertain whether 





AQUEOUS NITRIC OXIDE DELIVERY: DESIGN CONSIDERATIONS 
The study of the effect of NO on living systems requires an effective method for NO 
delivery in the aqueous phase. Aqueous NO delivery can be achieved either chemically 
with NO-donor compounds or physically by the mass transfer of gaseous NO to the li'quid 
phase. 
3.1 Chemical method of NO delivery. 
Certain compounds such as SIN-l and NONOates release NO in so.lution. Some of 
these compounds have potential medical use in treating hypertension, penile erectile 
dysfunction, respiratory distress syndrome, and some heart ailments [Kerwin et aI, 1995]. 
The NO-release kinetics of spermine and diethylamine NONOates have been characterized 
and modeled [Ramamurthi, 1996]. The release rate varies with time result ing in an 
unsteady-state concentration vs time profile in many experimental systems. 
3.2 Physical method of NO delivery. 
The physical method of NO delivery uses a semi-permeable membrane to separate a 
fl owing stream of liquid from a gas phase containing NO while allowing mass transfer of 
NO across the membrane. The gas phase consists of a mixture of NO with an inert gas 
such as nitrogen. The desired aqueous NO concentration is achieved by controlling the 
partial pressure of NO in the gas phase, the liquid flowrate, and the area available for mass 
transfer. 
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3.3 Design of NO delivery device. 
The delivery of NO is achieved by ·mass transfer of gaseous NO to pH 7.4 aqueous 
phosphate buffer across a flat sheet of polydimethylsiloxane (Silastic®) membrane. A 
previous method to deliver NO to the aqueous phase used Silastic® tubing [Tamir et al., 
1993]. However, the concentration was not predictable using this method. The present 
design uses a SilasticlE' sheet in preference to Silastic\E' tubing as the NO delivery rate vs 
partial pressure ([NO] vsPNO) data obtained using the Silastic® sheet were found to be 
linear in contrast to the non-linearity with the tubing. 
The NO delivery device permits liquid flow through a conduit of rectangular cross-
section bounded at the top and bottom by sheets of Silastic<E'. NO gas flowing on the 
outside of the Silastic® membranes initiates di:flUsion through the membranes and into the 
liquid. The benefits of choosing a configuration where NO diffuses across semi-permeable 
membranes enclosing a flowing stream of liquid are 1) the abililty to control the rate of 
NO transport into solution, and 2) knowledge of the steady-state solution to equations 
predicting the mass transfer rate of a species from gas to liquid .across membranes 
enclosing the li.quid stream. 
3.3.1 Physical characteristics and sizing. 
The delivery device consists of three longitudinal parts made of stainless steel and held 
together by stainless steel .!\llen-head screws (see Figure 3.1). The central part has an inlet 
and an outlet for liquid at both ends of a 15.3 cm long rectangular slot having a cross-
section 0.5 em wide x 0.3 cm deep. The ends of the slot were rounded to minimize 



















Figure 3. 1. Nitric oxide delivery device (See text for dimensions) 






5 mil Silastic® membrane laminated to 0.16 em thick rectangular sheets of plexiglas using 
silicone adhesiv,e. The membranes which are compressed between the plexiglas and steel 
prevent liquid leaks while also preventing the entry of air into the liquid stream. Each 
plexiglas sheet contains a 2.5 em 10ngxO.5 em wide rectangular opening that is 10.2 em 
from the liquid inlet. The opening was thus placed in order to minimize the reaction of 
NO with dissolved oxygen inside the delivery device while ensuring that the flow is fully 
developed before it reaches the opening. The liquid flow is maintained at 3.0 mllmin using 
a peristaltic pump. 
The plexiglas opening exposes the membrane to the gas by providing a permeable 
interface for mass transfer into the liquid. The NO delivery rate is controlled by varying 
the length of the opening and hence the mass transfer area. Maximum delivery can be 
achieved by increasing the plexiglas opening length to 15.3 crn which is the length of the 
slot containing the liquid. In addition, chambers 15.3 em long, 0.5 ern wide, and 0.3 em 
deep were fabricated above and below the central portion of the device. The chambers 
were designed to allow gas to enter via an inlet, partially diffuse across the membrane into 
the liquid through the openings in the plexiglas, and leave through an outlet. Gas leaks 
from the chambers are prevented by two rubber gaskets placed in between the plexiglas 
sheets and chambers. 
3.4 Design of the vessel containing tbe cells. 
A vessel for containing the cells was desjgned to be placed downstream of the delivery 
device. This vessel was designed to hold a sufficient number of cells to produce 
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detectable insulin concentrations while ensuring exposur,e of all the cells to a uniform and 
steady-state NO concentration as stated in Aim # 1. 
3.4. ] Design requirements. 
In order to satisfy Nm #1, the vessel for containing the cens must have the following 
characteristics: 
1) The vessel must have a large area to contain a sufficient number of l3-cells, 
grown as a monolayer, to produce a detectable concentration of insulin in the liquid. 
2) The NO concentration in the vessel must be uniform. 
3) The volume of the vessel should be as small as permissible (by requirement # I), 
so that the formation of any reaction products of NO with the components of the 
buffer/culture medium would be minimized.. This would reduce or el iminate the 
uncertainty following experiments that any observed effects on cens are caused by species 
other than NO. 
].4.2 Ph.ysical characteristics. 
Based on the criteria outlined in the preceding section, a stirred vessel that would 
approximate an ideal continuous stirred tank reactor (CSTR) was desired to hold the cells. 
The following design decisions were made. 
~) The vessel was to be constructed of stainless steel to protect it from corrosion 
by NO and to eliminate the formation of additional species by reaction with the vessel that 





2) The stirring would be achieved using a magnetic stirr,er to rotate a stirbar made 
of magnetic material that would not react with NO or be oxidized by the culture medium. 
3) The clearance between the stirbar and the bottom of the vessel would be 
sufficient to minimize the shear on the cells caused by the stining. 
4) For future work, an additional chamber to contain macrophages, separated 
from the stirred chamber by a semi-permeable membrane, would be provided. 
5) The liquid inlet would be at the base of the vessel while the outlet would be 
near the top. This would facilitate removal of air bubbles when filling the vessel. 
3.4.3 Vessel sizing and operating conditions. 
The diameter of the vessel was determined by calculating the area required to contain a 
monolayer of f3-cells that would generate detectable amounts of insulin. This was 
accomplished using the basal (unstimulated or minimally stimulated by glucose) rate of 
insulin secretion of several cell types as reported in literature. A liquid flowrate of3.0 
mlfmin was chosen based on economic considerations. A liter of culture medium costs 
~$15. Therefore for a ten hour long experiment using nearly 2 liters, the cost would be 
$30. A low flowrate would also ensure laminar flow whruch is essential for modeling the 
mass transfer. 
The minimum number of cells necessary to achieve a detectable insulin concentration 
and the area required to contain the cells were estimated for Rat f3-cells [Corbett and 
McDanid, 1995], Syrian hamster f3-cells [Santerre et al., 1981], and the tumor cell lines 
INS-1 [Asfari et al., 1992] and HIT-5B5 {Santerre et al., 1981] using their basal insulin 
secretion rates. The results are summarized in Table I. 
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TABLE I 
INSULIN SECRETION BY VARIOUS CELL TYPES AND VESSEL S.IZING 
Cel) Type Rat Hamster INS-l HIT-5B5 
Basal Insulin Secretion 79.8 270.0 191.4 20.0 
(IlU/minil06 ceIJs) 
Basal Insulin Concentration at 26 .6 90.0 63.8 6.67 
CSTR outlet (IlU/mIIl06 cells) 
Minimum Number of Cells 6x 1 04 2x104 2.5 x 104 2. 3x106 
Minimum Vessel Diameter (cm) 0.42 0.32 0.27 1.07 
Stimulated Insulin Concentration 
at CSTR outlet (~LU/ml, based on 13.6 12.2 3.5 3.07 
the minimum number of cells) 
Glucose Concentration for 20 10 20 10 
stimulation (mM) 
Note: The diameter of rat ~-cells and INS cells is - 15 ~Lm while that of hamster p-cells 
and HIT cells is -20 11m. 
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A sample calculation using rat ~-cells follows. The basal rate of insulin secretion by rat 
~-cens is 1 ng/2000 cells/3 hours which is equivalent to 2.78 ng/minl} 06 cells. Using the 
molecular weight for human insulin, whruch is 5808 Da, and the fact that 6.0 nmoles of 
insulin equal one International Unit [Volund, 1993] (the unit for measurement of proteins 
such as enzymes, cytokines, hormones etc., represented as U) the rate is 79.77 !-LU/minll06 
cells. Therefore, the insulin concentration at the CSIR outlet is 26.6 !-LU/mllI 06 cells for a 
flowrate of3 .0 mYmin. For a radioimmunoassay (RIA) sensitivilty of 1.5 JlU/rnl 
(CoatACount, Diagnostic Products Corporation, Los Angeles, CA) this corresponds to a 
minimum number of cells of approximately 60,000. Assuming an average cell diameter of 
15 11m [Bonner-Weir, 1991], the minimum area required for these cens., each of which is 
assumed to occupy a squar1e whose side is equal to the cell diameter, is 0.135 cm2. A 
stirred v,essel of 0.42 cm diameter would have this area. 
Since rat ~-cens required the largest vesse] diameter, except for HIT cells, and 
provided a comparatively higher concentration of insulin in the liquid outlet stream, the 
vesseJ sizing was based on data for these cells. The minimum number of rat ~-cells 
required (see Table I) was mUltiplied by a factor of IOta provide a margin of safety for 
the vessel diameter design. This cell number was again multipl.ied by IOta account for the 
possibility of reduced insulin release by dysfunction or death of cens following exposure to 
NO. Therefore, a vesseJ diameter of5.4 em is required to contain 6.0x106 cells. 
A vessel of 5.5 em diameter (see Figure 3.2) was fabricated from stainless steel 
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six million since it is not possible to perfectly plate the cells in a monolayer adjacent to 
each other. The height of the vessel is 0.8 em to account for a 0.3 em clearance between 
the stirbar and the bottom of the vessel, a 0.3 em thickness of the stirbar fabricated from 
magnetic stainless steel (SS 416), and a dearance of 0.2 cm between the stirbar and the 
top of the vessel. The stirhar is 4.4 cm long x 0.6 em wide and is held in place on a small 
projection from the base of the vessel by a teflon washer and nylon screw. A chamber 
provided above the vessel is separated from the stirr'ed lower chamber by a circular 0.2 cm 
thick plexiglas sheet. For future experiments studying the effect of macrophages and their 
products on ~-cells, the two chambers will be separated by a semi-permeabl.e membrane. 
The stirred vessel is provided with two diametrtcally opposite holes which function as the 
inlet and outlet for the hquid. The outlet is located near the top of the vessel while the 
inlet is located at the bottom. This facilitates the elimination of air from the chamber 
during liquid filling. The volume of the vessel and the 118 inch Swagelok® fittings at the 
inlet and the outlet is ~21.0 ml. Therefore, the theoretical residence time is 7.0 min for a 
flowrate of 3.0 ml/min. 
3.4.4 Design el'aiu(ttion. 
A residence time distribution (RTD) study was undertaken to determine how well the 
vessel approximated an ideal CSTR. Methylene blue (Aldrich Chemical Company, WI, 
USA) was used as the tracer. The vessel was evaluated at flowrates of3 and 6 rnllmin and 
stir speeds of 20, 30 and 40 rpm. A pulse of dye was injected at the inlet and the 
absorbance at 652 nm was measured with time using a spectrophotometer (Model UV-
l601, Shimadzu Scientific Instruments, Inc., Maryland, USA) The point of measurement 
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and the outlet of the stirred vessel were separated by 60 em of 0.32 em OD teflon tubing 
(residence time 0.4 min). 
As shown in Figure 3.3, the eurve of absorbance vs time decayed exponentially after 
initially attaining a maximum value. For an ideal CSTR, the concentration can be 
expressed as a function of time and ini~ial concentration such that 
C = C e '[ u 
Equation 3. I may also be written as 
t 




Since the absorbance is proportional to the concentration of tracer, the residence time of 
the vessel was determined by fitting the absorbance vs time data to Equation 3.2 (see 
Figure 3.4). The average residence times at 20, 30, and 40 rpm were 7.37±0.42, 
7.43±0.42, and 7.66±O.lS min, respectively. Therefore, there was no significant 
difference between the residence times at these stirring speeds. It was decided to use 30 
rpm for the stir speed as it seemed to provide adequate mixing ~ithout subjecting the cells 
to too much shear. The mean residence times for flowrates of3 .0 and 6.0 ml/min, 
irrespective of the stir speed, were 7.47±0.37 and 3 .43±0.1 9, respectively. The mean 
residence time for a flow of 6.0 mllmin was 10% lower them half the corresponding value 
for a flow of 3.0 mllmin and is approximately equal to the theoretical residence time for a 
flow of 6.0 ml/min. 
The vessel was recently modified by increasing its depth to 95 mm as compared to the 
earlier 8 mm. The new volume of the vessel is 25 0 ml. This corresponds to a theoretical 
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Figure 3.3. Residence time distribution curve of stirred vessel. The fl owrate is 3.0 mllmin 
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Figure 34. Residence time plot. The flow rate is 3.0 mUmin and the stir speed is 30 rpm 






















residence time of 8.3 min at a fiowrate of3.0 mVrnin.. Experiments using a step change in 
dye concentration at the vessel inlet were then performed to determine its residence time 
and to determine the reason for the earlier observed differences in the theoretical and 
experimental residence times. The concentration of the dye was measured in a 
spectrophotometer at a point separated from the vessel outlet by 56 em of 0.32 em D.D. 
teflon tubing. For a flowrate of 3.0 mJ/min the residence time of this tube is 0.4 min as 
determined using the 0.16 em inner diameter. The absorbance vs time data from the 
experiments was used to determine the collective residence time of the vessel and the 
teflon tube. The total residence time is given by 
(3.3) 
where all the absorbance data (C) from the beginning (t = 0) up to the time taken to 
achieve steady state is used in Equation 3.3. 
The total expeJimental residence time is 8.5±O.4 min. For systems in series, the total 
residence time is the sum of the residence time of each system. Therefore, subtracting the 
tube residence time of 0.4 min from the total experimental residence time yields a vessel 
residence time of8.1 min. This is in excellent agreement with the theoretical vessel 
residence time of8.3 min. However, the residence time determined by fitting the 
absorbance decay data to Equation 3.2 is 8.8±0.7 min. The discrepancy between this 
vaJue and the vessel theoretical value is likely explained by the fact that the exponential 
data represents not only the vessel behavior but also the tube behavior. If the tube does 
not represent a perfect plug flow then the vessel residence time will be convoluted, 
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causing the experimenta~ residence time to be greater than the corresponding theoretical 
value of the vessel. This is likely the reason why analysis of data obtained using a pulse 
input gave an experimental residence time greater than the theoretical vessel residence 
time. A likely reason the data for a flowrate of6.0 ml/min gave a measured residence time 
value that is in good agreement with the theoretical residenoe time may be that the flow 
was more representative of plug flow at the higher flowrate as compared to the flowrate 
of 3.0 ml/min. In any case, since the vessel outlet concentration is likely to be affected by 
the radial position ofa pulse injection residence time analysis, using a step change is more 
reliable. 
The preceding observations together with the nature of the graph presented in Figure 
3.3 lead to the conclusion that the originally designed vessel closely approximated an ideal 
CSTR. Economic considerations dictate the use of a flowrate of 3 mllrnin. In addition, 
the theoretical residence time of7.0 min is appropriate for use in the model and will be 
used in preference to the possibly inaccurate value of7.5 min. 
]0 
CHAPTER 4 
MOD.ELING NITRlC OXIDE DELIVERY 
Modeling the mass transfer of NO to solution and its sU!bsequent reactions in the stirred 
vessel with the dissolved oxygen constitutes an important step in achieving well defined 
NO delivery rates and concentration profiles. A validated model would enable 
achievement of the desired NO concentrations in the stirred vessel without resorting to 
experimental verification. 
4.1 Modeling mass transfer of NO in the delivery device. 
The rate of mass transfer of a species (i.e. NO) from gas to liquid across semi-
permeable membranes that form the upper and lower sides of a rectangular duct 
containing the liquild has been predicted [Colton and Lowri,e, 1981]. The model 
predictions are based on the assumptions of fully developed laminar flow, steady-state 
conditions, homogenous fluicis, and the absence of aqueous mass transfer across the 
permeable membranes. 
4.1.1 Modelformulation. 
The mass balance over a differential length, dz, of the delivery device (see Figure 4.1) 
representing plug flow is written as 
(4.1) 
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Figure 4.1. Mass balance analysis of delivery device. 
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partial pressure Pi is Co. The relationship of Co to Pi is Co = H Pi, where H the Henry' s 
law constant. Q is the liquid volumetric flowrate, k, is the average overalJ mass transfer 
coefficient, and C is the concentration in the bulk liquid. Equation 4.1 is subject to the 
boundary conditions Cm = 0 at z = 0 and em = Cout at z = L. Integration of Equation 4.1 
yields (4 .2) 
The value of k, is determined from the overall Sherwood number which is defined in 
terms of 1<0, the aqueous diffusivity (D), and the distance separating the two membranes 
(h) such that 
Sh = k oh 
o D (4.3) 
Sho is representative of the dimensionless concentration gradient at the boundary layer and 
is indicative of the overall resistance to mass transfer (resistance:x. ] ISho) Analogous to 
electrical circuits where resistances in series are added to give the total resistance, the 
resistances of the permeable membrane and the adjacent liquid boundary layer are added 
to yield the overall resistance to mass transfer. Therefore, the o,:,erall Sherwood number is 
related to the Sherwood numbers for the membrane waH (Shw) and liquid boundary layer 
J 1 ] 
--=--+--
Sh o Sh\\ Sh r 
(4.4) 
The wall Sherwood number is similady defined as Sh" = kw h where kw is the mass 
D 
transfer coefficient characterizing mass transport through the wall. Using the permeability 
p' of the Silastjc ' ~ membrane, k" is expressed as 
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), 
k = lOOOP· 
w H8 
where p. is in mol cm-I S-I cnillg-1, H is in M cmHg-I, and 0, the thickness of the 
membrane, is in cm. Thus, 




Using the model ofCoIton and Lowrie [1981], Shfis determined from Sh"" the membrane 
length (L), the diffusivity (D), the average velocity (V), and the membrane separation 
height (h). Assuming that a negligible amount of NO reacts between its point of entry into 
the liquid and the outl,et of the delivery device, the NO concentration (Cout) at the outlet of 
the delivery device is determined using Equation 4.2. 
4.1.2 Shenvood numbers. 
The values of the aqueous diffiIsivity, Henry's constant, and membrane permeability for 
respectively, whereas at 37°C, the corresponding values are 5.1 x 10-5 cm2 s- J, 2.1 x 10-5 M 
cmHit. 5xlOJ2 mol cm-1 S-I cmHg-1, respectively [Lewis, 1994]. The permeability at 
37°C is approximately twice the reported value at that temperature, in order to account 
for the effect of heating the Silastic® membrane during sterilization in an autoclave before 
use in experiments at 37°C [Lewis, 1994]. The values of L, w,and hare 2.5 em, 0.5 em, 
and 0.3 cm, at all temperatures, respectively. The average velocity over the cross-




At 25°C, Shw is 84 and the model predicted Shr to be '1 .5. This indicates that the 
Ii.quid boundary layer resistance is approximately 7 times the wall resistance and is thus the 
controlling fac tor in the mass transfer of NO. Similarly, at 37°C the values of Sho, Sh", 
and Shf are approximately 9, 120, and lO, respectively, again indicating a major role for 
the liquid boundary layer in controlling the aqueous NO concentration achieved at the 
oudet of the delivery device. 
4 .. 1.3 Model validation. 
Experiments were performed at 25°C and 37°C to measure the NO concentration at 
the delivery device outlet for comparison with the model predictions. 
4.1. 3. J Experimental setup. 
A gaseous mixture of 10% NO and 90% nitrogen (HP. Gas Products, Inc. , Baytown, 
TX) was mixed with ultra high purity nitrogen (UHP N2) (Sooner Airgas, Stillwater, OK) 
to achieve the req uired gaseous partial pressures . The 10% NO I N2 mixture made it 
possible to achieve low partial pressures required to ,establish aqueous NO concentrations 
on the order of a few nM without excessive use of nitrogen. Flowmeters (porter 
Instrument Co., Hatfield, PA, USA) with capacities of 10 scem and 1000 sccm were used 
to control the flowrates of the NOIN2 mixture and UHP N2 •. respectively. Before 
conducting any experiments, the flowmeters were calibrated using a bubble flowmeter. 
Both the flowmeters permitted flow that was higher than the set value by 5-7%. The ratio 
of actual flow to the setpoint was 1. 066 for the NO/N2 flowmeter whereas it was 1.053 
for the UHP N2 flowmeter. A check valve (OKC Valve and Fitting Co. , Oklahoma City, 
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OK) having a crack pressure of 0.3 psi was used in the NOlNz gas line immediately 
following the flowmeter in order to prevent backflow In the UHP N2 line, an O2 gas 
purifier (Model DGP-125-Rl, VWR Scientific, CA, USA) was introduced before the 
flowmeter to completely remove oxygen and preclude any fonnation (by oxidation of NO 
in the gas phase) of nitrogen dioxide (N02) that could diffuse into the liquid and fonn 
reaction products that were detrimental to the function of cells. To ensure complete 
removal ofN02 following mixing, the gas was bubbled through a solution of 4M sodium 
hydroxide (NaOH). The exp,erimental setup is shown in Figure 4.2. 
The liquid flowing through the delivery device consisted of 0.01 M phosphate buffer 
(PH 7.4). The buffer was contained in a 1 liter conical flask open to the atmosphere and 
was stirred vigorously using a tdlon coated stirbar to saturate the solution with oxygen. 
The solution was pumped to the delivery device by a peristaltic pump that used teflon 
tubing (Masterflex®, Model 77390-00, Cole-Parmer Instrument Co., IL, USA). When 
performing experiments at 37°C, the flask was partially immersed sn a water bath 
maintained at 38°C (to compensate for heat losses during flow) 9Y an immersion circulator 
(Model 71, VWR Scientific Products). 
The NO concentration was measured at the delivery device outlet using an 
amperometric probe (ISO-NOP, World Precision Instruments, Sarasota, FL, USA) having 
a measurement sensitivity of 1 nM. The probe has a membrane covering a platinum 
electrode where oxidation of NO generates current. The electrode is enclosed by a 
slender steel body which is inserted into a luer lock adapter that fits securely Olll a tee luer 
fitting. The te,e ]uer was attached to the teflon tubes (0.32 cm D.D.) that conveyed 
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Figure 4.2. Experimental apparatus. 
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Oc scavenger .. 
the NO solution to and from the tee. The current value of the probe response was 
displayed by a battery powered me~er and recorded by an integrator (Model HP 3395, 
Hewlett Packard Co., USA). Experiments at 37°C required the delivery device and probe 
to be located inside an incubator (Model 1510E, VWR Scientific, CA). In addition two 
holes were drilled in the sides of the incubator to provide convenient entry and exit points 
for the tubes conveying the liquid. All the tubing used in the experimental setup, except 
where specified, was 0.32 cm O.D. teflon tubing while all the tube fittings were stainless 
steel 
4. 1.3.2 NO calibration procedure. 
The NO probe was ca.librated prior to measuring NO concentrations. This was 
achieved by recording the electric current values corresponding to known NO 
concentrations. At 25°C, known concentrations of NO were generated by bubbling gas 
through buffer solution contained in a 125 ml conical flask. The solution was 
deoxygenated prior to calibration by bubbling UHF N2 for 1 hour. After deoxygenation 
different NO saturation concent rations were achieved by varying the partial pressure of 
NO and quantifying the NO concentration from NO solubility data [Lange, 1967]. The 
saturated solution was pumped at 3.0 mllmin through a closed loop cont.aining the NO 
probe and the pump. The values of the electric current (nA) generated at NO 
concentrations 0[0.3 1,061, and 0.92 ~lM, obtained with NO partial pr,essures of 
1. 52 x 1O-~, 3.03 X 10-3, and 4.55 x ]0-3 atm, respectively, were recorded to arrive at the 







At 37°C the calibration was performed by bubbling NO containing gas through buffer 
in a one liter flask placed in the water bath. However, the same partial pressures of NO 
that were used at 25°C resulted in NO concentrations of 0.25, 0.50 and 0.75 11M due to a 
reduction in NO solubility at 37°e The probe was placed inside the incubator maintained 
at 37°C while the NO solution was pumped at 3.0 ml/min to the probe. Unlike at 25°C, 
the NO conoentration was not recycled. 
4.1. 3. 3 Experimental procedure. 
Experiments at 25°e and 37°e followed different procedur,es due to the extreme 
temperature sensitivity of the NO probe. The probe is sensitive to temperature variations 
and temperature changes as small as o.osoe change the current output. The probe was 
stored in a vial containing deionized water when not in use for short periods of time (less 
than a week), such as in between experiments. This regenerates the electrode in the probe 
by removing the NO molecules adjacent to it. 
Experiments at 25°e were initiated by priming the pump with buffer solution . 
Immediately after this, the delivery device was filled by holding it in a vertical position to 
ensure removal of all the air bubbles. A short piece oftefion tubing, attached at one end 
to a short tygon tube linked to a luer fitting, was used to connect the delivery device outlet 
to the tee that would hold the probe. The probe was inserted into the tee only after liquid 
began flowing from the open arm of the tee. This was done to eliminate air bubbles within 
the tee. The remaining arm of the tee was left open so that the liquid dripped into an open 
trough. It is important to note that the probe, being extremely pressure sensitive, gave a 









the higher hydrostatic pressure in flowing liquid. The flow setting was adjusted to give 
3.0 rnVmin of flow as verified by flow measurement using a graduated cylinder. This was 
important as even a slightly different flow changed the probe response due to an increase 
or decrease in the hydrostatic pressure experienced by the probe. 
The probe was used to validate the NO concentration values predicted by the model 
(Equation 4.2) at NO partial pressures of 1.25x W-3, 2.51 x lO-3, 5.00x 10-3, and 1 O.OOx 10-3 
atm using UHP N2 and NOIN2 mixture flowrate combinations of99.0 and 1.25 sccm, 97.0 
and 2.5 sccm, 95.0 and S.O seem, and 90.0 and 10.0 sccm, respectively. After adjusting 
the liquid flowrate to 3.0 ml/min, the UHP N2 flow was turned on and set to the 
appropriate flowrate . The probe response was allowed to reach steady-state. The NOIN2 
gas was then turned on and set to the appropriate flowrate. When the probe response 
reached a steady value, it was r,ecorded and the UHP N2 and NOIN2 mixture flowrates 
were adjusted to values corresponding to the next higher NO partial pressure. This was 
repeated until readings for all the NO partial pressures had been obtained. The NOIN2 
mixture flow was then turned offwhile leaving the UHP N2 flow on for a few minutes in 
order to sweep away all the residual NO from the delivery device. After turning off the 
liquid flow, the probe was removed from the tee and its tip washed with deionized water 
before returning it to the vial containing deionized water for storage. 
At 37°e the experimental procedure was initiated with the connection of the pump to 
the delivery device inlet:. The pump was then primed and the deJivery device was fi]]ed 
with the warm buffer solution. All of the tubing, whether inside the incubator or outside, 








to dampen the effect of the slight changes in temperature inside the incubator on the probe 
response. After the delivery device was filled, the probe was insert,ed into the tee as 
explained previously. Once the probe was set up, the incubatm door was closed until the 
experiment ended. The flow was then set to 3.0 mVmin. 
At 37°C, the heating-cooling cycle of the incubator played an important role. The 
incubator turned on the heat for about 1.5 minutes approximately once every 20 minutes. 
The heating was followed by a period of cooling of about 18 minutes. The effect of 
heating on the probe response became evident when the heating stopped. The response 
increased over the next 9 to 10 minutes by about 0.10 nA and then stayed nearly constant 
for about 2 minutes before beginning to decrease. The response decreased by about 0.08 
to 0.09 nA (slowly in the beginning) during the next 4 to 5 minutes and continued to drop 
even when the heating turned on again. Fortunately, since the time taken for the NO 
concentration (or current) to reach steady-state was about 5 to 7 minutes, it was possible 
to observe the cycle of this increase/decrease in response due to heating/cooling and start 
the NO gas flow through the delivery device ~30 seconds before the r.esponse peaked. 
This meant the response could achieve steady-state before the cooling caused a significant 
decrease in the value. The steady-state response was noted and the NOfN2 mixture was 
then turned off. This procedure was repeated for each NO exposure. Thus, the probe 
response for each NO exposure was determined using a slightly different baseline or 
reference value and was properly accounted for. The NO partial pressures were the same 
as those used at 25°C. 
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4.1.3.4 Results. 
Calibration of the probe at 25°e yielded a linear current output (nA) vs NO 
concentration profile having slopes ranging from 0.80 to 0.95 nNIlM. At 37°C slopes of 
the calibration curves were in the range of 095 to 1.20 nAl~lM (see Figures 4.3 and 4.4). 
Figures 4.5 and 4.6 show the experimental outlet NO concentrations as well as the outlet 
concentrations predicted by the model. At 25°e the measured values deviated from the 
model predictions by ± 7% or lower. At 37°e, the deviation was ± ] 2% in the 
concentration corresponding to the highest partial pressure of JO.OOx lO-3 atm and ± 7% or 
lower in the concentrations corresponding to the other three partial pressures. It is likely 
that the greater error in the highest concentration response at 37°e is due to the 
temperature s,ensi6vity of the NO probe response. 
Figure 4.7 compares the NO concentration predictions at the delivery device outlet for 
flowrates of2.7, 3.0, and 3.3 mllmin. Small changes in the liquid f10wrate cause a small 
change in the rate of mass transport of NO At 2.7 rnllmin, the NO concentmtion values 
at all NO partial pressures are higher by 5.5% while at 3 J. ° mlllJ1in they are 7% lower as 
compared to corresponding values at 3.0 mllmin. 
4.2 Modeling the NO concentration in the CSTR. 
The CSTR designed to contain the ~-cells was connected to the outlet of the delivery 
device using a 15.5 em long piece 0[0.32 cm 0.0. teflon tubing. The tubing between the 
delivery device and the CSTR was mode.lled as a plug flow reactor (PFR) where the PFR 
outlet NO concentration is the inlet NO concentration for the CSTR. For a well-stirred 
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Figure 4.4. NO probe calibration curve at 37°C. 
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vessel, the NO concentration at the outlet is the NO concentration to which the cells are 
exposed. 
4.2.1 The model 
The outlet NO concentration predicted for the delivery device is used as the inlet 
concentration for the PFR. A mass balance over a differential Length of the PFR yields 
(4.8) 
where T is the average residence time z Iv. The rate of the aqueous reaction between NO 
and O2 is given by the equation 
(4.9) 
The rate constant kJ is 2.1 x 1 0-6 and 2Ax W-6 M-2s-! at 25°C and 37°C, respectively [Lewis 
and Deen, 1994] . The saturated aqueous O2 concentrations at those temperatures when 
exposed to air are 265 and 223 JlM, respectively [Lewis, 1995]. Integration of Equation 
4.8 using boundary conditions C = Cout att = 0 and C = Cpfr at T = Tpfr yields 
(4.10) 
The assumption made in the integration is that the oxygen concentration in the liquid 
remains unchanged at its saturation value for the given temperature. This is justified as the 
NO concentration in the liqUId is less than 1 % of the aqueous O2 saturation concentration 
and NO reacts in the stoichiometric ratio 4: 1. The residence time ('[pfr) in the short tube 
connecting the delivery device to the CSTR is 0.1 min based on the 0.16 cm inner 
diameter of the tube, a length of 15.0 cm and a flowrate of 3.0 rot/min. Considering the 
concentration computed from Equation 4. W to be the inlet NO concentration for the 
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CSTR, the NO concentration at the outlet of the CSTR (CCSIr) is determined using a 
simple mass balance 
(4.11) 
Equation 4. 1 I was solved to yield 
(4.12) 
where "'t'cslr (= 7.0 min) is the residence time in the CSTR. 
4.2.2 Experimental setu.p a.nd proce,dure. 
The experimental setup was the same as earlier described in section 4.1.3.1 with the 
addition of the CSTR at the delivery device outlet. The CSTR was placed on a stir plate 
(Micro Stir modd II, Wheaton Instruments, NJ, USA) which operated at 30 rpm (see 
Figure 4.2). For experiments at 37°C, the CSTR and the stir plate were kept inside the 
incubator with the delivery deyice, and the NO probe was connected to the outlet of the 
CSTR to measure the NO conoentration of the CSTR. 
The experiments at both temperatures were initiated as explained in section 4.1.3.3. 
The only difference was that the CSTR and delivery device were not connected until the 
delivery device had been filled. The CSTR was filled by tilting it s~ightIy so that the outlet 
was the highest point inside the CSTR. This facilitated the removal of all the air from the 
CSTR. The NO probe was then inserted in the CSTR outlet tubing. 
For experiments at 25°C, after recording the baseline reading, the NOIN2 mixture flow 
was turned on and set to obtain a partial pressure of 1.25x 10.3 atm. Steady-state was 
achieved in about 30 minutes. Once the probe response for the partial pressure of NO had 
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been recorded, the experiment proceeded to the next higher partial pressure. This carried 
on until the readings for all the same partial pressures used earher (Section 4.1.3 .3) had 
been obtained. In some cases, the above procedure of measuring NO concentration 
requiring the probe to be continuously exposed to NO for about two hours caused the 
electrode of the probe to become saturated with NO. This affected the readings, so a 
modified procedure was adopted. In this new procedure, the experiment was be begun by 
recording the baseline value of probe current output, followed by disconnection of the tee 
containing the probe from the CSTR. The probe was maintained in this condition for the 
next half hour while the NO concentration achieved steady state. The probe was then 
reattached to the CSTR and the response was recorded. Following this, the tee was 
disconnected once again and the partial pressure of NO increased to the next higher value 
while the tee was flushed with deionized water. The probe remained in deionized water for 
the next half hour until it was time for the next reading. This procedure yielded 
satisfactory results but could not be used at 37°C as opening the incubator frequently 
caused large temperature changes that would affect the probe response. 
At 37°C, the NO concentration measurements were made continuously with only one 
experiment being performed per day in order to allow the electrode to be refreshed by a 
sufficiently long period of cleansing in the deionized water. The procedure of 
measurement required knowledge of the increase and decrease in the NO response due to 
heating and cooling of the incubator. The flow of the NOfN2 mixture was turned on just 
before the baseline response reached its peak. The NO concentration (probe current 
output at steady-state) was obtained when the current increased to its next peak value 
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which would usually be about 30 minutes from the time the NO flow was turned on. This 
procedure worked only because the rise and fall in the response during heating and! cooling 
were the same or the clifFerence was a negligible fraction of the response. However on 
cold days, the response cycled more frequently and with greater amplitude making it very 
difficult to achieve a well-defined steady-state probe response. This was, however,. 
alleviated to a great extent by wrapping the CSTR in fiber glass insulation. In fact, 
avoiding direct contact between the CSTR or delivery device and other solid surfaces 
helped dampen the fluctuations in the probe response caused by temperature variations. 
4.2.3 Results. 
The results at 25°C and 37°C are shown in Figures 4.8 and 4.9. At 25°C, the measured 
values of NO concentration differed from the model predictions by ± 21 % or less, whereas 
the NO concentrations measured at 37°C deviated by ± 7% or less from the model 
pr,edictions. The residence time used for the CSTR predictions was 7.0 min. For a 
residence time of7.5 min and a NO partial pressure of 0.01 atm, the mode] predicted NO 
, 
concentrations that were only 2% lower than the corresponding predictions using a 
residence time of7.0 min. This is not surprising given that the reaction is second order in 
NO concentration and the concentrations for this study are in the nanomolar range. 
4.3 Problems encountered in the experiments. 
Numerous problems were encountered with the probe, delivery device, peristaltic 
pump, and the stirbar in the CSTR. Some of these problems were remedied. This section 
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describes the problems encountered in perfoITIling expenments at 25°C and 37°C and 
identifies the experimental uncertainties to be aware of when interpreting the results. 
4.3.1 Problems with tire NO probe. 
Most of the problems encountered dealt with the probe. The electrode in the probe did 
not function properly when an o-ring was used. This o-ring was to be slid on to the sleeve 
of the probe to prevent the luer lock fitting from sliding off However, the o-ring was not 
needed as the luer lock fitting fit tightly on the steel sleeve of the probe. In addition, the 
o-ring fit tightly on the probe and when positioned on a sensitive 0.5 em long region at the 
tip of the probe it hampered normal function of the probe due to the pressure it exerted on 
the electrode. The o-ring in this position lowered the sensitivity of the probe by a 
significant amount. This was the first indication of the probe's pressure sensitivity, a fact 
corroborated by observations of changes in the probe response caused by introduction of 
the probe in a flowing stream ofliquid. The response also changes when the flowrate is 
changed, although the flowrate change may be a mere 0.2 mllmin. The probe response 
was found to vary in direct propol1ion to the applied pressure. ' 
The radial position of the probe tip in the tee also affected the response by about 15%. 
The response for the same partial pr,essure of NO was greatest near the walls of the tee 
and the least at the center. The tightness with which the luer lock fitting is connected to 
the tee also seems to affect the response. The tighter the fitting is locked onto the tee, the 
higher is the probe response. This change in the probe response may be due to an increase 
in pressure on the probe tip or due to a change in radial position of the probe tip in the tee. 
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The probe is also very highly temperature sensitive. Even a change in temperature as 
sman as o.osoe can change the probe response. This has heen noticed in experiments at 
37°C where the probe response was found to increase and decrease with rise or fall in 
temperature even though the incubator controls the temperature to within ± 0.3°c. In 
addition, although the probe apparently is able to measure NO concentrations as high as 
20.0 ~M, the electrode gets saturated with NO when exposed to concentrations above 1.0 
~M fo r more than ~4S minutes . There is an immediate and sharp decrease in the 
sensitivity of measurement upon saturation and the probe response falls . Finally, the 
presence of bubbles in the liquid also adversely afFects the experiment. The bubbles cause 
the probe response to jump wildly. Conversely, if sudden inexplicable spikes in the 
response occur then it strongly indicates the presence of bubbles in the liquid. 
When functioning properily, the probe should have a sensitivity in the range 0.5-1.0 
nA/IlM. The sensitivity should always be greater than 0 .5 and the closer the sensitivity is 
to 1.0 nA/J..lM the better the condition of the probe . The probe is a very sensitive 
instrument that needs patient and careful handling to perform r~liab ly for a long period of 
time. If the response is seen to slowly drift higher with time even in the absence of NO, 
there may be a microscopic hole in the membrane covering the electrode and the sleeve 
needs to be replaced. However, this behavior may also be due to a variation in the 
temperature of the liquid. Although the probe has many problems, it is a convenient 
instrument for measuring nanomolar concentrations of NO . The probe can be used to 





4.3.2 Problems with the delivery device. 
Another potential source of problems was the delivery device. In the beginning, it was 
noticed that the membrane was getting distended due to the pressure applied by the gas. 
The gas was constrained to leave the chamber via an outlet that was the same diameter as 
the inlet. The distention in the membrane increased the area available for mass transfer 
resulting in measured NO concentrations that were 1.5-2 times the values predicted by the 
model. This situation was remedied by doubling the diameter of the gas outlets. The way 
the device is filled also affects its performance. The presence of air bubbles on the 
membrane where the mass transfer takes place largely reduces the mass transfer to the 
liquid. The drop in NO concentration may be as much as 80% of the model NO 
concentration predictions. The best way to fill the delivery device is to hold it vertical so 
that the displaced air can leave easily. 
4.3.3 Problems with the pump and stirbar. 
Some relatively minor problems were caused by the peristaltic pump and the stirbar in 
the CSTR. The pump uses teflon tubing and unless the tubing tightly fits over the rollers, 
the flow will vary as the free end of the tube carrying the liquid is raised or lowered. This 
is because the hydrostatic pressure head acting on the liquid changes as the tube is raised 
or lowered causing the flow to vary. This problem is eliminated by ensuring that the tube 
inside the pump presses tightly against the rollers, otherwise the change in flow will 
change the probe response. 
The problem with the stirbar was that, although it was made of stainless steel, it was 
not heat hardened and prolonged exposure to oxygen rich buffer tarnished the surface. In 
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addition, the stirbar appeared to react with the NO in the CSTR, affecting experimental 
measurements. Reaction with the stirbar can decrease the NO concentration by as much 
as 80% when compared to the predicted values. To remedy this, the stir bar was 
electroplated with gold to prevent reaction. However this thin layer of gold began to wear 
offin places subjected to frictional contact with the body of the CSTR. The stirbar was 
found to rust badly when exposed to Krebs-Ringer buffer solution used in experiments 
with cells. Therefore, a new stirbar design has been proposed. This stirbar will consist of 
a block of teflon provided with a longitudinal hole containing a bar magnet. The hole wilE 
be sealed with silicone adhesive to prevent the magnet from reacting with NO. The use of 
a screw and washer will be obviated by providing the stirbar with an integral cylindrical 
projection that fits into the hole provided for the screw in the CSTR. This projection will 
not only act as a pivot but also prevent changes in the position of the stirbar when the 
CSTR is tilted during filling. 
4.4 Conclusions. 
The results are extremely satisfactory considering the sensitivity of the measuring 
instrument and the low concentrations utilized. The model can be used to predict the NO 
concentration in the CSTR with an accuracy of ± 7% or less at 37°C. There may be no 
sharp threshold concentration beyond which tbe function of ~-cells is hampered. 
However, there will likely be a species dependent range of NO concentrations and other 
specific criteria, such as time of exposure, that would be needed to be achieved before 
cellular dysfunction occurs. The results presented tn the preceding sections amply qualify 
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the model to be a useful instrument in reliably achieving desired aqueous NO 
concentration exposures to cells. 
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CHAPTER 5 
INVESTIGATING THE EFFECT OF NITRIC OXIDE ON f3-CELLS 
Preliminary experiments were conducted by exposing .f3-cells to NO in order to test the 
feasibility of using the designed experimental apparatus. Cells of the insulin secreting 
tumor cell-line INS-l [Asfari et al., 1992] were used for the trial runs. Liquid samples 
containing insulin were collected from cell ,experiments and assayed to determine the effect 
of NO on insulin secretion. 
5.1 Materials and methods. 
RPMI-1640 without sodium bicarbonate but containing II mM glucose, donor calf 
serum, 2-mercaptoethanol, HEPES, penicillin-streptomycin, and trypsin EDT A were 
purchased from Life Technologies, Inc. (Grand Island, NY). Sodium pyruvate, poly-L-
ornithine, bovine serum albumin (BSA), and D-glucose were obtained form Sigma 
Chemical. Co. (St Louis, MO). Hexahydrated calcium chloride (eaCh), magnesium 
sulfate (MgS04), dibasic potassium phosphate (KH2P04) , and sodium chloride (NaCl) 
were purchased from Fisher Scientific (Fair Lawn, NJ). Sodium bicarbonate (NaHC03) 
and potassium chiorid,e (Kel) were obtained from EM Science (Gibbstown, NJ). 
5.1.1 Cell culture conditions. 




grown in culture medium consisting of RPM I-I 640, 1 mM sodium pyruvate, 50 j:.lM 2-
mercaptoethanol, 10 mM HEPES, 2 glliter NaHC03, 10% donor calf serum, and 1 % 
penicillin-streptomycin. 
The INS-I cells were cultured in tOO mm culture dishes, passaged at ~80% confluency 
and incubated at 37°C in air containing 5% CO2 . The doubling time of the cells was -3 
days. It was noticed that the cells were infected with bacteria so 0.05 ml of gentomycin, 
obtained as a gift from Dr. Tim Burnham, Department of Microbiology, Oklahoma State 
University, was added to each culture dish to kill the infection. Thebact:eria decreased in 
number to a large extent but could not be completely eliminated. However, the cells were, 
still used in the trial experiments. 
5.1.2 Preparation of cells for experiments. 
For use in the experiments, cells were plated on 55 mm polycarbonate discs with a 
central hole of 10 mm diameter so as to fit in the CSTR. The discs were placed in 60 mm 
diameter lids of small glass culture dishes, attached to the bottom of the lid with two drops 
of silicone adhesive to prevent them from floating on the culture medium, and sterilized in 
an autoclave. Cell adhesion to the discs was facilitated by coating the discs with poJy-L-
ornithine using a ] 0 mg/liter solution ofpoly-L-ornithine in sterile water. This solution (5 
ml) was allowed to stand in the lids containing the attached discs for 3 hours., following 
which the solution was removed and the lids washed twice with sterile water. 
On the day prior to the experiment, the cells were detached from the 100 mm culture 
dishes by incubation with 0.05% trypsin-EDT A for 5 min . Culture medium (10 ml) was 
then added to the dishes following which the cell suspension was centrifuged at 1000 rpm 
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for 5 min. The supernatant liquid was discarded and the cens were resuspended in cultur,e 
medium and plated on the discs at a concentration of ~5 xl 06 cells per disc. The lids 
containing the dishes were then placed in the 100 mm cultur,e dishes and incubated 
overnight so that the cells could attach to the discs . 
5.1.3 Treatment of cells prior to the experiment. 
An hour before the experiment, the culture medium was removed from the lids 
containing the discs, and replaced with ~ 7 ml of Krebs-Ringer-hi carbonate-HE PES buffer 
(KRBH), pH 7.4, containing I mM glucose. KRBH is composed of 134 mM NaCl, 3.5 
rnM KCt, 1.2 rnM K2HP04, 0.5 mM MgS04, 1. 5 mM CaCh, 5 mM NaHC03, 10 mM 
HEPES, and 0.1 % BSA The cells were incubated at 37°C in this buffer for about one 
hour before transfer of the disc to the CSTR 
5.2 Experimental setup. 
The experimental setup is shown in Figure 5.1 . For the experiments, glucose free 
KRBH and KRBH + 20 mM glucose contained in two 1.0 liter bottles maintained at37°C 
were used. The buffer solutions were gently stillTed using two teflon coated stirbars 
rotated by a stirplate under the water bath. The ]ids onhe bottles contained a hole ~5 mm 
in diamet,er. This hole was covered with a septum attached to the cap using silicone 
adhesive. Air containing 5% CO2 was purged through the vapor space in the bottles using 
3.8 cm long, sterile 20 gage needles provided with luer fittings. Two needles mounted on 
sterile 25 mm teflon filters, having a pore size of 0.2 ~m (Cole-Parmer Instrument Co., 
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Figure 5.1. Experimental aparatus for cells. 
Fraction coJector 
inserted into the septa on the bottle caps. The gas flow from the COiair tank was split 
using a tee and conveyed to the filters on the inlet needles of the two bottles by tygon 
tubing. Liquid was drawn from the bottles using two needles made from 0.16 em O.D. 
stainless steel tubing. Both the needles convey~ng liquid from the bottles were attached to 
0.32 em O.D. teflon tubes connected to a teflon J-way valve. The peristaltic pump was 
connected downstream of the 3-way valve using teflon tubing. The pump outlet was 
connected to the delivery device inlet while the delivery device outlet was connected to 
the CSTR inlet. The liquid from the CSTR outlet was collected in test tubes held in a 
fraction collector (Eldex Laboratories, Napa, CA). . . 
5.3 Experimental procedure. 
Before starting the experiment, the teflon tubing used in the peristaltic pump was 
connected to the needJes inserted in the KRBH bottles and to the delivery device. The 
delivery device outlet and the needles were then covered with autoclave paper and the 
entire assembled unit was autoclaved. The CSTR was also autoclaved after separating the 
stirbar and screw and covering the inlet and outlet with autoclave paper. The stirbar and 
screw were wrapped separately in autoclave paper. The washer was not used in these 
experiments. The glucose free KRBH and the KRBH with 20 mM glucose were prepared 
earlier inside a sterile hood and stored at 4°C in sterilized bottles having caps without 
holes. The tubes and the tee conveying the gas were not sterilized as the microorganisms 
in the gas stream were kept out of the system by the filters. 
The experiment began with replacement of the culture medium in the ceIl culture dishes 
with KRBH + I mM glucose, foJlowed by incubation of these lids as explained earlier in 
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Section 5.1.3 . Following this, sterile stirbars were added to the two bottles containing 
glucose free KRBH and KRBH + 20 mM glucose. The caps on the bottles were replaced 
by caps with septa. The four sterile 20 gage needles and the correspond.ing filters wer,e 
connected and inserted into the septa, so that each bottle had a gas inlet and outlet. The 
filters were then connected to the tygon tubes, following which the bottles were 
transported with the entire assemblage and placed in the water bath. The stir plate was 
switched on and set to stir at a gentle speed to prev,ent frothing. 
The CSTR was then opened inside the sterile hood and the disc containing the cells 
was placed in the CSTR. At the beginning of the experiment the discs were observed 
visuaUy and the cells appeared well attached to the disc. However, the discs appeared 
only -15% confluent (- 1.5 x 1 06 celLs) with little sign of any bacteria. KRBH was then 
added to the CSTR. The stirbar was put in place and the screw replaced. The top of the 
CSTR with the plexiglas plate was replaced and fastened to the lower portion of the 
CSTR. The CSTR was then connected to the delivery devioe. The entire assembly 
consisting oftbe 0.16 cm O.D. needles, the tubing inside the p~mp, the delivery device, 
the CSTR, and the 0.32 ,em 0.0. teflon tubes linking aU these to ,each other was brought 
out of the sterile hood and arranged as shown in Figure 5.1. The liquid outlet needles 
were removed from the wrapping of autoclave paper and wiped with alcohol swabs before 
insertion into the bottles. 
After assembling the apparatus, the needle and the tube belonging toO the bottle 
containing KRBH + 20 mM glucose was fined with the buffer solution. The filling was 
stopped when the liquid emerged from the 3-way valve and proceeded into the tube 
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leading to the pump. The valve was then adjusted to allow flow ofthe glucose :free 
KRBH. The pump was primed and the delivery device held inclined while it filled. The 
CSTR was then inclined slightly and filled so as to eliminate potential air bubbles. The stir 
plate under the CSTR was set at 30 rpm and the incubator door shut, to be opened only at 
the end of the experiment. The fraction coneetor containing 135 test tubes was set to 
,collect samples every 2 min. The flowrate was adjusted to 3.0 mllmin so that each test 
tube would have a sample volume of 6 ml. 
The experiment consisted of four phases each lasting one hour. Phase 1 (first hour) 
consisted of exposing the cells to glucose free KRBH in ord,er to determine the basal 
concentration of insulin in the .liquid. In Phase 2 (second hour), the cells were expos,ed to 
KRBH containing 20 mM glucose to determine the concentration of insulin when the cells 
were stimulated. During the third phase, NO was introduced into the buffer solution via 
the delivery device to observe the effect of NO on the cells. In the fourth and final phase, 
the NO was turned off to see whether the insulin concentration would readjust to pre-NO 
exposure levels. This was to observe whether the dt:ect ofN~ was temporary or 
permanent. 
5.4 Insulin RIA of the samples. 
Thirty samples were collected fOF each phase of the experiment. Six evenly spaced 
samples from each set of30 were selected for the insulin assay. The assay was conduct,ed 
using Dr. MaCann's facilities in the School of Veterinary Medicine, Oklahoma State 
University. The assay used five insulin standards prepared with human insulin (RIA kit 
purchased from Diagnostic Products Corporation, Los Angeles, CA). The standards were 
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0, 5, 15, 50 and 200 IlU/ml of insulin respectively. There were also two sampl·es 
containing known concentrations of insulin. These were used to test the accuracy of the 
calibration. 
5.4.1 Principle of the assay~ 
The assay involves the use of test tubes coated on the inside with insulin antibody. A 
sample containing insulin and a tracer containing radioactive 1125 labeled human insulin are 
pipetted into a tube one after the other. The radioactive insulin and human insulin bind 
competitively with the antibody. The radioactivity in the tube is then measured using a 
gamma counter. The concentration of normal insulin is inversely proportional to the 
amount of radioactivity detected. 
5.4.2 Assay procedure. 
The insulin assay was conducted using the prepared standards and tracer already 
available in Dr. MaCann's laboratory. Each sample/standard is pipetted into two RIA test 
tubes and the final concentration is an average of the two valu~s obtained from the test 
tubes. Since six samples were selected from each of the four phases, there were a total of 
24 samples. In addition, there were five standards and two test samples. Two 
polyethylene test tubes containing only the tracer were also used . Initially the tubes were 
numbered from 1 to 64 beginning with the polyethylene tubes. Following this, 200 ILll of 
each sample/standard was pipetted into two tubes beginning with the standard containing 
no insulin. A different pipette tip was uses for each sample/standard. Next, 1.0 ml of 
tracer was pipetted into each tube. The tubes were then arranged in a test tube rack, 
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covered with aluminum foil, and agitated by shaking to improve mixing of the contents. 
The test tubes were then incubated in a water hath at 37°C for three hours. At the end of 
three hours, the liquid from the tubes was decanted and the tubes shaken dry. The test 
tubes were then transferred to racks used with the gamma counter. The racks were placed 
in the gamma CDunt,er and the assay of the radioactivity begun after selecting the 
appropriate protocol. The gamma counter assayed the various tubes and provided a 
printout of the results. 
5.5 Results. 
The results ofthe assay indicated that the insulin concentrations were (0.20-0.75 
IlU/ml). These values are lower than the sensitivity (1 .5 IlU/ml) of the assay. The data 
points were scattered showing no obvious trend and a lot of the time, even the readings 
from the two tubes containing the same sample were very different. Howev,er, 2-3 
samples from each phase of the experiment had similar values of insulin concentration. 
Assuming this to be the general trend in that phase of the experiment, the readings from 
tubes having values very much higher or lower than the generafly similar value were 
discarded. The remaining values of insulin concentration (/-tU/ml) were plotted with time 
as shown in Figure 5.2. The plot displays an approximate basal insulin concentration of 
0.13 IlU/ml estimated from samples collected in the first hour. With glucose stimulation 
(second hour), a steady rise is observed in the insulin concentration. During the third hour 
when tbe cdls are exposed to NO, the insulin concentration decreases from ~O.3 ~U/ml to 
~0.2 /-tU/ml. The fourth hour of exposing the cells to NO free buffer fails to bring the 
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Figure 5.2. Effect of NO on insulin secretion. 
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insulin concentration back to the levels of Pbase 2 indicating a permanent decrease in the 
secretion rate of insulin. 
The lJ"esults of a second experiment were very sporadic which prevented meaningful 
iterpretation. Again, the insulin concentrations measured had lower values than the 
sensitivity of the assay. 
5.6 Problems encountered in the experiment. 
There were two main problems that were noticed during the experiment. At the end of 
tbe experiment when the CSTR was inspected,a lot of air bubbles were present. The 
cause could either be a leak upstream or a leak in the CSTR itself. The first seems to be a 
more plausible reason because a leak in the CSTR has never before been noticed and the 
fact that the o-rings are used in the CSTR to seal the contact between the lower vessel and 
the plex~glas. Furthermore, no bubbles were noticed upstream of the delivery deVice so 
the leak must have been in the delivery device. Although this problem had not yet been 
confronted, the possibility for a leak of air into the liquid exists as it is only the membrane 
itsdfthat seals the joint between the plexiglas and the central steel part . Also the stirbar 
had a considerable amount of rust deposited on it. Closer inspection revealed that the 
gold layer covering the magnetic steel had worn off at the surfaces of contact with the 
CSTR. Somehow, the presence of several components ilrl the buffer, several of which are 
salts, had accelerated the rust formation. The remedy to this problem is to replace the 
stirbar with one made of teflon as explained eadier in Chapter 4, Section 4.3.3 . 
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5.7 Probl,ems. with the ass3ly. 
Severam filcts came to light after the first assay. Primarily, the number of ceUs need to 
be increased to bring the insulin concentrations to values that ar,e higher than the 
sensitivity of the assay. Secondly, the assay uses human insulin standards whereas the 
INS-l cells synthesize rat insulin. 
5.8 Conclusions. 
The results clearly demonstrate that the designed apparatus is feasible for use in 
delivering NO to cells. In the light of the results, it seems extracellular NO inhibits insulin 
secretion by pancreatmc p-cells. A reliable assay would lend greater credibIlity to the 
results and is essential for achieving future goals. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
A novel and reliable method for NO delivery that eliminates the presence of species 
other than NO and nitrite in the liquid was developed. Previous cell experiments using 
NO-donor-compounds to deliver NO to cells had drawbacks. There was uncertainty in 
interpreting the results produced by the experiments due to the presence of sev,eral species 
in addition to NO which could have caused harm to the ~-cens. In addition, the 
experimental apparatus used did not ensure that ceUs were exposed to uniform and 
steady-state NO concentrations; Therefore, an apparatus capable of delivering a wide 
range of NO concentrations in the liquid with relatively minor modifications was 
developed. This method of NO delivery eliminates the major shortcomings observed in 
previous experiments using NO-donor compounds by providing an environment in which 
pancreatic ~-cells are exposed to uniform and steady-state NO concentrations devoid of 
other damaging species. 
The delivery of NO in the liquid was modeled. The measured values of the NO 
concentrations in the CSTR fall within ±7% of the model predictions at 37°C, Thus the 
model has thus been successfully validated as required by Aim #2 and will prove useful in 




Finally, the apparatus was demonstrated to work reliably in experiments using cens. A 
detailed procedure for setup and conduct of experiments was worked out for performing 
experiments using p-cells. This method has the advantage that it can be used to evaluate 
the effects of NO on a variety of different mammalian cells without any major 
modifications. 
6.1 Conclusions. 
In the light of the preceding obseIVations the following conclusions are reached: 
• the mass transfer model accurately predicts the NO concentration at the delivery 
device outlet. 
• the stirred vessel behaves as an ideal CSTR. 
• the reaction model accurately predicts the NO concentration in the stirred vesseL 
• it is feasible to use the designed apparatus in experiments with cells. 
• the thesis aims have been achieved. 
6.2 Recommendations. 
The goals in the immediate future are to use this model and delivery method for 
determiming the effect of extracellularly generated NO on f3-cells from rats. A better assay 
should be developed using rat insulin to prepare the standards for calibration. A method 
of determining the percentage of dead cells should also be established to evaluate the 
effect of NO on cell viability. The next step should then be to use human f3-cells 
Experiments should be performed using a monolayer of f3-cells as well as whole human 
71 
islets to see if NO affects the ~-ceiJ viability and function ~n the same way and to the same 
extent in either case. 
Experiments could also be performed using culture medium containing one or a 
combination of several cytokines. The NO generation induced by the cytokines could be 
measured using the probe while also determining the effect of cytokines on insulin 
secretion and cell viability. The cytokine concentration could be varied by changing the 
concentrations in the culture medium. The simultaneous ·effect of exposing cells to 
extracellularly and intracellularly generated NO could be examined by concomitantly using 
the delivery device to deliver NO to cells. 
A suggestion regarding improvements to the present design ofthe CSTR is to replace 
the stirbar currently in use with a identically sized stir bar made of teflon constructed as 
explained in Section 4.3.3. Another suggestion with regard to the CSTR is to cut out the 
bottom and replace it with an identical removable bottom occupying the same position. 
Tbis removable bottom would make it easier to remove the disc containing the cells after 
the experiment, facilitating subsequent staining and determination of the number of dead 
cells. In order to eliminate potential leaks in the delivery device, the membrane should be 
stuck Ito the plexiglas as well as the central part. 
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